Hawryluk P. Kent — SEC Form 4 filings
SEC reporting owner CIK 1673991. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-08.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-09-13 to 2026-05-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 88,500 shares, $1,332,953 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 607 shares, $17,931 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 50,000 shares @ $10.69 ($534,500) in MBX Biosciences, Inc., filed 2025-02-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. (MBX) | President & CEO, Director | 9 | 3 legs · 88,500 sh · $1,332,953 | 1 leg · 607 sh · $17,931 | 15 |
Form 4 filings — Hawryluk P. Kent
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-08 | 4 | MBX Biosciences, Inc. (MBX) | Sale (S): 607 @ $29.54 | EDGAR |
| 2026-03-16 | 4 | MBX Biosciences, Inc. (MBX) | Purchase (P): 18,500 @ $28.41 | EDGAR |
| 2026-02-27 | 4 | MBX Biosciences, Inc. (MBX) | Option exercise (M): 28,768 @ $16 · Option exercise (M): 28,768 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 35,250 @ $0 · Grant/award (A): 164,500 (derivative) @ $0 | EDGAR |
| 2025-10-28 | 4 | MBX Biosciences, Inc. (MBX) | Option exercise (M): 182,859 @ $3.25 · Option exercise (M): 182,859 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | MBX Biosciences, Inc. (MBX) | Purchase (P): 20,000 @ $13.64 | EDGAR |
| 2025-02-05 | 4 | MBX Biosciences, Inc. (MBX) | Purchase (P): 50,000 @ $10.69 · Grant/award (A): 243,000 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | MBX Biosciences, Inc. (MBX) | Conversion (C): 283,846 · Conversion (C): 115,914 · Conversion (C): 2,015,681 (derivative) · Conversion (C): 345,705 (derivative) · Conversion (C): 1,396,762 (derivative) · Conversion (C): 76,969 (derivative) · +1 more | EDGAR |
| 2024-09-13 | 4 | MBX Biosciences, Inc. (MBX) | Grant/award (A): 120,436 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1673991 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →